Novel therapeutic strategies for patients with metastatic triple-negative breast cancer

Triple-negative breast cancer (TNBC) remains the most aggressive subtype of breast cancer. In the presence of distant metastases, the median overall survival does not exceed 14 months. TNBC is an extremely heterogeneous group of tumors, it includes both tumors extremely sensitive to chemotherapy and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Inna P. Ganshina, Olga O. Gordeeva, Mariam Sh. Manukian
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2021
Materias:
Acceso en línea:https://doaj.org/article/a99aa8bbbad543218bc93d48c8adcbf6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!